Results 121 to 130 of about 5,648 (180)

Comparative evaluation of viability PCR reagents highlights the superior efficacy of PMAxx azo dye for bacterial and viral viability discrimination using real-time and digital PCR. [PDF]

Microbiol Spectr
Hongsibsam T, Prasertsopon J, Siripurkpong P, Niyomdecha N.   +3 more
europepmc   +1 more source

Advanced Stage CTCL, PTCL with Cutaneous Involvement

The Internet Journal of Dermatology, 2009
openaire   +1 more source

Multiorgan Peripheral T-Cell Lymphoma Presenting as Isolated Cardiomyopathy. [PDF]

JACC Case Rep
Memon AA, Darrah E, Monty T, Tao R, Jacobson T, Kalidindi S, Weber B, Kettelkamp N, Harrington AM, Lewandowski D.   +9 more
europepmc   +1 more source

Cure of a CD20-positive peripheral T-cell lymphoma-NOS with CHOPE regimen plus surgery a case report and literature review. [PDF]

Front Med (Lausanne)
Chi C, Wang S, Xu M, Shi Y, Ran X.
europepmc   +1 more source

Insights into Nodal T-Follicular Helper Cell lymphomas and Peripheral T-Cell Lymphomas, Not Otherwise Specified, in Slovenian Patients: Mutational Landscape, Clinicopathological Characteristics, and Outcomes. [PDF]

Ann Hematol
Erzar E, Sindi-Ivanova V, Dirnhofer S, Boltežar L, Ocvirk J, Kloboves Prevodnik V, Tzankov A, Gašljević G.   +7 more
europepmc   +1 more source

Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort study. [PDF]

Cell Commun Signal
Liang JH, Hua W, Yin H, Li Y, Zhang XY, Liang JH, Zhu LQ, Gao R, Wang CX, Shao Y, Pan BH, Zhang XY, Wu JZ, Ou QX, Li JY, Shen HR, Wang L, Xu W.   +17 more
europepmc   +1 more source

Erratum: Dührsen U, Bockisch A, Hertenstein B, et al. Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial. <i>Blood Neoplasia</i>. 2024;1(3):100018. [PDF]

Blood Neoplasia
europepmc   +1 more source